Two biotechnology companies are collaborating on creating genetic therapies delivered with lipid nanoscale particles using non-viral mechanisms to reach target cells. . . . → Read More: Moderna, Biotech Partner on Non-Viral Genetic Drug Delivery
|
|||||
       |
 One comment - (Comments are closed)  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, chemistry, engineering, equity, genomics, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences 
A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M One comment - (Comments are closed) Finance, Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, university, venture capital 
An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease. . . . → Read More: Start-Up Licensing Antibody Eye Drops for Dry Eye Disease Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, clinical trials, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals, university 
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, Europe, genomics, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, preclinical, U.K., university 
A university lab created and licensed to a biotechnology company a model human ovary made of functioning cells for female reproductive health applications. . . . → Read More: Human Ovary Organoid Model Demonstrated, Licensed Comments are closed Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, medical device, stem cells, university 
A new enterprise began public operations to provide researchers with better analytical tools for making sense of mountains of complex genomics and related biomedical data. . . . → Read More: Start-Up Creating Software to Simplify Biomedical Analytics Comments are closed Intellectual property, New products biomedical, computer science, engineering, entrepreneurs, genomics, licensing, life sciences, mathematics, physical sciences, software, university 
Data in the chart are compiled by PatentSight, a service of LexisNexis, that show the seven leading holders of machine learning and other A.I. patents by company in 2017 and 2021. . . . → Read More: Infographic – Chinese Companies Lead in A.I. Patents Comments are closed Intellectual property China, computer science, engineering, patent, physical sciences, statistics 
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases 
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations, New products Asia, biomedical, biotechnology, cancer, chemistry, Japan, licensing, life sciences, pharmaceuticals, physical sciences, university 
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal Comments are closed Intellectual property, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, licensing, life sciences, pharmaceuticals, physical sciences |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts